Furosemide EP impurity D
| Product Name | Furosemide EP impurity D |
|---|---|
| Alternate Names | Furosemide Impurities, Impurities of Furosemide |
| CAT No. | CS-O-07845 |
| CAS No. | 5046-19-5 |
| Category | Impurities |
| Stock | IN-Stock |
| Mol. Wt. | 391.40 g/mol |
| Mol. For. | C₁₇H₁₇N₃O₆S |
| Hazardous | This is a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | Furosemide |
| Purity | Not less than 90 % |
| Therapeutic | Anti-Hypertensives |
| Smileys | N[S](C1=C(C=C(NCC2=CC=CO2)C(C(O)=O)=C1)NCC3=CC=CO3)(=O)=O |
| Canonical Smiles | C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)NCC3=CC=CO3 |
| InchIKey | NQRLIXFNJZQNKV-UHFFFAOYSA-N |
| Inchl | InChI=1S/C17H17N3O6S/c18-27(23,24)16-7-13(17(21)22)14(19-9-11-3-1-5-25-11)8-15(16)20-10-12-4-2-6-26-12/h1-8,19-20H,9-10H2,(H,21,22)(H2,18,23,24) |
| IUPAC | 2,4-bis(furan-2-ylmethylamino)-5-sulfamoylbenzoic acid |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
Furosemide EP impurity D, also known as 4-Chloro-5-sulfamoylanthranilic acid, is a chemical compound that is commonly used in the pharmaceutical industry as a reference standard for quality control purposes. This compound is a known impurity that can be found in Furosemide, a loop diuretic medication that is used to treat edema and hypertension.
Furosemide EP impurity D is a crystalline solid that has a molecular formula of C7H6ClNO4S. It has a melting point range of 236-238°C and a purity of not less than 98%. This compound is soluble in water, ethanol, and methanol, but insoluble in ether and chloroform.
As an impurity of Furosemide, Furosemide EP impurity D is monitored during the production and quality control of the medication. Impurities in pharmaceuticals can affect the safety, potency, and efficacy of the drug, which is why it is important to control and limit their presence.
Analytical methods such as high-performance liquid chromatography (HPLC) and gas chromatography (GC) can be used to detect and quantify Furosemide EP impurity D in Furosemide samples. By monitoring and controlling the impurity levels, the quality and safety of Furosemide can be ensured for patient use.
Get an Instant Quote
Related Compounds
Tetrahydro Furosemide | Furosemide EP impurity A | Furosemide oxo impurity | Furosemide Imine impurity | Furosemide Impurity 14 (N-Nitroso-Furosemide) Sodium salt | Furosemide Dessulfamoyl impurity | Furosemide EP impurity B | Furosemide Impurity 1 Hydrochloride (Furfurylamine Hydrochloride) | Furosemide Impurity 8 | Tetrahydro Furosemide | Furosemide Amide Impurity | Furosemide Dichloro impurity | Furosemide Deschloro impurity | Furosemide Impurity 1 | Furosemide EP impurity E |